fb-pixel Skip to main content
Biotech and health care

Latest stories

More biotech and health care stories

US will stretch monkeypox vaccine supply with smaller doses

US health officials on Tuesday authorized a new monkeypox vaccination strategy designed to stretch limited supplies by allowing health professionals to vaccinate up to five people — instead of one — with each vial.

Who should get the monkeypox vaccine? What to know as Mass. limits shots to one dose only

The second dose, normally administered 28 days later, will be offered after supplies increase. Here are answers to some common questions about the monkeypox vaccine.

Once the ‘it’ supplement, vitamin D is losing its sparkle

Vitamin D supplements, regularly consumed by millions of Americans, have not held up to the considerable hype of warding off many common, dreaded diseases.


For some in the LGBTQAI+ community, a monkeypox vaccine offers both hope and anxiety

The focus on the disease spreading among gay and bisexual men has led to concerns that monkeypox could be used to stigmatize the gay community, similarly to the AIDS crisis.

Karuna’s experimental schizophrenia drug succeeds in advanced study

If approved by the FDA, the Boston biotech’s medicine would be the first new type of treatment for the disease in decades.

Pfizer buying Global Blood Therapeutics in $5.4 billion deal

Pfizer is buying sickle cell drug maker Global Blood Therapeutics in an approximately $5.4 billion deal as it looks to accelerate growth after its revenue soared during the pandemic.

‘It feels yucky’: Pediatricians say they’re discarding vaccine doses for the youngest amid lack of demand

In Massachusetts, only 11 percent of children younger than 5 have received their first shot.

Mass. advocates, experts say more monkeypox vaccine is needed as feds scale up national effort

“We’re hopeful this declaration will lead to a dramatic scaling up of vaccine development,” said one Boston expert.